Nexalin Technology, Inc. (NasdaqCM: NXL)
Health Care · Health Care Equipment & Supplies · US
$0.33
-5.11% today · -56.5% 1Y
Nexalin Technology, Inc. (NasdaqCM: NXL) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $7.54M and employs 8 people.
Over the last twelve months the share price has lost 56.5%, trading between 0.31 and 2.00.
Tweenvest scores Nexalin Technology, Inc. across four factors: quality 27/100, value 43/100. Its strongest factor is value.
NXL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $7.54M
- Revenue (TTM)
- $217.16K
- P/E
- —
- EPS
- -0.46
- Dividend yield
- —
- Beta (5Y)
- 4.04
- 52-week high
- $2.00
- 52-week low
- $0.31
- Avg volume (3M)
- —
- Shares outstanding
- 21.54M
- Employees
- 8
- Next earnings
- —
About Nexalin Technology, Inc.
Nexalin Technology, Inc. operates as a medical device firm specializing in the creation and advancement of neurostimulation therapies for mental health conditions in both the United States and China. The company commercializes its primary product, the Nexalin Device, which provides a non-invasive and drug-free treatment for anxiety and insomnia. This device functions by emitting a proprietary frequency-based waveform designed to elicit a beneficial response from mid-brain structures associated with various psychological disorders. Furthermore, Nexalin Technology is currently developing "Generation 2," a new medical device undergoing clinical trials. This future product aims to address a broader spectrum of health issues, including opiate addiction, persistent pain, Alzheimer's disease, and dementia. The company was founded in 2021 and has its headquarters in Houston, Texas.
- Listed since
- Sep 16, 2022
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $201.83B | $116.85 | +0.18% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $133.83B | $380.60 | +0.47% |
| Stryker CorporationNYSE: SYK | $126.37B | $332.00 | +0.77% |
| Medtronic plcNYSE: MDT | $119.49B | $93.79 | +0.47% |
| EssilorLuxottica Société anonymeENXTPA: EL | $87.56B | €162.35 | -0.52% |
| Boston Scientific CorporationNYSE: BSX | $73.00B | $50.74 | +0.73% |
| HOYA CorporationTSE: 7741 | $52.38B | ¥24,895.00 | -1.37% |
| Becton, Dickinson and CompanyNYSE: BDX | $52.30B | $192.00 | +2.33% |
Figures last refreshed Aug 18, 2026.